AMN HEALTHCARE SERVICES, INC. financials

AMN CIK 0001142750

Source: EDGAR filings · Built 2026-06-02T02:19:39Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 233.83M 239.53M 268.48M 577.90M 251.78M 219.12M
EBITDA 101.13M 71.11M 499.36M 784.21M 581.70M 243.45M
Working Capital -32.24M 49.13M 185.56M 235.71M 379.68M 110.78M
Net Debt 769.23M 1.09B 1.32B 796.43M 686.14M 921.58M
Gross Margin 28.35% 30.81% 32.98% 32.74% 32.87% 33.08%
Operating Margin -2.03% -3.44% 8.93% 12.34% 12.00% 6.24%
Net Margin -3.50% -4.93% 5.56% 8.47% 8.22% 2.95%
Return on Equity (ROE) -14.90% -20.80% 25.34% 42.55% 28.17% 8.62%
Return on Assets (ROA) -4.57% -6.08% 7.20% 15.37% 10.45% 3.00%
Current Ratio 0.94× 1.09× 1.28× 1.27× 1.39× 1.26×
Debt-to-Equity 1.25× 1.55× 1.62× 0.82× 0.75× 1.16×
Effective Tax Rate 5.30% 14.83% 25.89% 26.81% 26.25% 22.79%
Cash Conversion Ratio -2.82× -2.18× 1.77× 1.47× 0.93× 3.63×
Accruals Ratio -0.17× -0.19× -0.06× -0.07× 0.01× -0.08×
SBC % of Revenue 1.12% 0.78% 0.48% 0.57% 0.63% 0.85%
CapEx Coverage 7.56× 3.96× 3.59× 8.62× 5.70× 6.81×
Free Cash Flow Per Share $6.07 $6.27 $6.82 $12.88 $5.24 $4.59

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 13.97× 10.39× 17.96× 46.11×
P/FCF 2.60× 3.81× 10.97× 7.98× 23.34× 14.85×
FCF Yield 38.52% 26.22% 9.11% 12.53% 4.28% 6.73%
EV / EBITDA 13.60× 28.10× 8.31× 6.51× 11.12× 16.98×
P/S 0.22× 0.31× 0.75× 0.82× 1.45× 1.34×
P/B 0.94× 1.29× 3.41× 4.13× 4.98× 3.92×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.73B 2.98B 3.79B 5.24B 3.98B 2.39B
Cost of Goods and Services Sold 1.96B 2.06B 2.54B 3.53B 2.67B 1.60B
Gross Profit 774.06M 919.38M 1.25B 1.72B 1.31B 791.78M
Selling, General and Administrative Expense 593.02M 632.49M 748.44M 936.58M 730.45M 549.75M
Operating Expenses 829.53M 1.02B 911.15M 1.07B 831.60M 642.51M
Operating Income (Loss) -55.47M -102.67M 338.43M 647.10M 478.00M 149.26M
Income Tax Expense (Benefit) -5.36M -25.59M 73.61M 162.65M 116.53M 20.86M
Net Income (Loss) Attributable to Parent -95.70M -146.98M 210.68M 444.05M 327.39M 70.67M
Earnings Per Share, Basic $-2.48 $-3.85 $5.38 $9.96 $6.87 $1.49
Weighted Average Number of Shares Outstanding, Basic 38.52M 38.19M 39.17M 44.59M 47.69M 47.42M
Earnings Per Share, Diluted $-2.48 $-3.85 $5.36 $9.90 $6.81 $1.48
Weighted Average Number of Shares Outstanding, Diluted 38.52M 38.19M 39.34M 44.87M 48.05M 47.69M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 33.97M 10.65M 32.94M 64.52M 180.93M 29.21M
Assets, Current 545.38M 594.91M 841.68M 1.09B 1.35B 533.74M
Assets 2.09B 2.42B 2.92B 2.89B 3.13B 2.35B
Long-term Debt 767.05M 1.06B 1.30B 843.50M 842.32M 857.96M
Liabilities, Current 577.61M 545.78M 656.12M 857.93M 969.39M 422.96M
Liabilities 1.45B 1.71B 2.09B 1.84B 1.97B 1.53B
Stockholders' Equity Attributable to Parent 642.11M 706.62M 831.26M 1.04B 1.16B 819.68M
Common Stock, Shares, Outstanding 38.44M 38.08M 37.81M 41.88M 47.26M 47.05M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 269.46M 320.42M 372.17M 653.73M 305.36M 256.83M
Payments to Acquire Property, Plant, and Equipment 35.63M 80.89M 103.69M 75.83M 53.57M 37.70M
Net Cash Provided by (Used in) Investing Activities 4.30M -79.94M -412.49M -170.71M -107.40M -538.17M
Payments for Repurchase of Common Stock 0 0 424.74M 576.77M 2.69M 0
Net Cash Provided by (Used in) Financing Activities -295.89M -259.45M 10.73M -591.87M -34.90M 211.49M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AMN CIK 0001142750), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PBYI

PUMA BIOTECHNOLOGY, INC.

ADV

Advantage Solutions Inc.

FLWS

1 800 FLOWERS COM INC